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Organophosphate pesticides exert their toxic effects by cholinesterase 
inhibition and the consequent prolongation of the undesirable effects of 
accumulation of acetylcholine. The signs of toxicity include tremors, 
convulsions, lachrymation, defecation etc. However, sustained cholinesterase 
inhibition through sustained administration of organophosphates would lead 
to the gradual disappearance of the initial signs of toxicity over time, termed 
behavioral tolerance. The present study was undertaken to examine the 
activity levels of cholinesterases in different regions of rat brain during the 
development of behavioral tolerance to the organophosphate phosalone. 
Male albino rats were given a daily oral dose of phosalone (41.35 mg, 
equivalent to ¼ of LD50) every day for 15 days and the activities of 
acetylcholinesterase (AChE) butyrylcholinesterase (BuChE) and 
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pseudocholinesterase (PChE) were estimated at intervals at 1, 3, 9 and 15 
days of treatment. All the cholinesterases were inhibited, and this inhibition 
was found to vary among different brain regions at different times. Greater 
inhibition of AChE and BuChE activities was observed at 9 days, while for 
PChE it was recorded at 3 days. Recovery trend to normalcy was observed 
earlier in PChE compared to AChE and BuChE. The signs and symptoms of 
pesticide toxicity were mainly cholinergic. Inhibition of cholinesterases was 
well correlated with the appearance and severity of signs and symptoms. 
Tremors and convulsions in particular were more after 9 days. After 9 days, 
decline followed by disappearance of majority of the signs and symptoms was 
noticed while reduction in cholinesterase activities still continued, indicating 
the development of behavioral tolerance to phosalone. Among the brain 
regions, striatum recorded a greater decrease in cholinesterase activity. 
Earlier recovery of pseudocholinesterase activity seems to be an interesting 
phenomenon in regulating homeostasis of cholinesterases and in the 
development of symptomatic tolerance of phosalone. 
 




Organophosphate (OP) compounds act on the cholinergic system by 
inhibiting cholinesterases, leading to a marked increase of acetylcholine level 
in central and peripheral synapses (Arnal et al., 1990). Phosalone is a non-
systemic dithiophosphate insecticide and is used as a substitute for DDT in 
agricultural and domestic fronts. It has been reported that OP compounds 
differ greatly in their potency of inhibition (Singh, 1985). Sub-chronic and 
chronic exposure to low doses of majority of OP compounds leads to the 
development of tolerance (Russell and Overstreet, 1987; Swamy et al., 1993). 
Biochemical and behavioral alterations were noticed along with receptor 
mechanisms during tolerance development (Russell et al., 1986; Van Dongen 
and Wolthuis, 1989). Cholinergic system is mainly involved in this process 
of tolerance. Pseudocholinesterases for sometime have been implicated as the 
effective reducers of inhibitory power of many OPs (Pla and Johnson, 1989). 
In the present investigation the effect of phosalone on cholinesterases in 
different brain regions and the possibility of phosalone-induced tolerance 
(symptomatic) were assessed during the treatment period of 15 days. 
 
African Research Review Vol. 3 (2), January, 2009. Pp. 20-30 
Copyright: IAARR, 2009 www.afrrevjo.com                     22 
Indexed African Journals Online: www.ajol.info 
 
Methodology 
Male albino Wistar rats weighing 130±20 g were used. Four animals were 
housed per cage and allowed access to food and water ad libitum. Technical 
grade (98% purity) phosalone [O, O- diethyl-s- (6-chloro-1-3 ben 30XO3ol-
2(3H)-O-methyl) phosphorodithiote], obtained from Volhro Ltd., India was 
used. Control animals received normal saline and the experimental rats 
received it along with phosalone. LD50 values were determined by Probit 
method (Finney, 1971). ¼ LD50 of phosalone was given by oral intubation 
daily for 15 days. Signs and symptoms were noted at regular intervals of 3h, 
6h, 12h, and    24h and pooled later. The observations of tremors and 
convulsions were quantified into arbitrary units in the scale of 0=no signs, 
0.2=slight (slow tremor on head); 0.4=moderate (faster tremor of the head 
trunk and limbs); 0.6=high (more intense tremors) and 0.8=severe. Similar 
scale was developed for convulsions, viz., 0.0=none, 0.1=slight, 0.2 moderate 
and 0.3 high. 
Both control and experimental animals were sacrificed by cervical 
dislocation and the brain areas, viz. the cerebral cortex (CT), cerebellum 
(CB), hippocampus (HP), striatum (ST) and medulla (MD) were quickly 
dissected out from the isolated brains following the standard anatomical 
markings (Glowinski and Iverson, 1966) on to a chilled Petri dish placed on 
crushed ice. The activities of acetylcholinesterase (AChE), 
butyrylcholinesterase (BuChE) and pseudocholinesterase (PChE) were 
estimated by the method of Ellman et al. (1961). For estimating BuChE and 
PChE activities, true cholinesterase inhibitor BW 284 C51 dibromide was 
used (20mM).  The enzyme activities were expressed as µmoles of 
acetylthiocholine/ butyrylthiocholine hydrolyzed/mg protein/min. 
Mann Whitney ‘U’ test for behavioral scores, and one way ANOVA by 
following the Student's Newman-Keuls test were used to analyze the 
statistical significance.      P values of 0.05 or less were considered 
significant. 
Results 
The signs and symptoms observed were tremors, convulsions, involuntary 
urination, defecation, lachrymation, salivation and sweating. These signs and 
symptoms were developed after 12h to 24h of oral dosing. The tremors 
commenced from 2nd day, reaching the peak in terms of severity on the 9th 
day from where tremors showed a downward trend with a steep fall from the 
12th day, returning to normalcy by the 15th day. Convulsions were found to 
Phosalone-Induced Changes in Regional Chlinesterase Activities in Rat Brain… 
Copyright: IAARR, 2009 www.afrrevjo.com                     23 
Indexed African Journals Online: www.ajol.info 
 
set in only from the 5th day. The convulsions were always slight to moderate 
in the scale with peak on the 9th day (data on other signs and symptoms are 
not shown). The distribution of cholinesterases in the brain regions was found 
in the order of AChE: ST>HP>CT>MD>CB; BuChE: ST>MD>HP>CT>CB; 
PChE: MD>HP>ST>CT>CB. After 24 h the inhibition of BuChE was found 
to be greater than that of AChE and PChE. After 3 days the PChE activity 
was inhibited more than AChE and BuChE activities. Both AChE and 
BuChE activities were found inhibited when recovery in PChE activity was 
noticed after 9 days.  
 
Further recovery in AChE and BuChE activities was noticed by 15 days, 
which was in general comparatively less than that in PChE.  Among the brain 
regions the AChE activity of cortex was inhibited more after 1 day (69%) 
whereas in almost all the areas BuChE activity was inhibited (60-85%) more 
in striatum followed by hippocampus and cortex.   PChE activity was 
inhibited less in cortex when the inhibition of (35-45%) was noticed in other 
areas. Interestingly, greater inhibition of PChE was noticed in striatum 
followed by medulla, hippocampus and cerebellum. AChE inhibition was 
progressive in all the areas from the 1st day to the 3rd and 9th day (except in 
cerebellum). BuChE inhibition was noticed after 3 days compared to the 
recovery trend in 1 day and the inhibition of PChE was further progressive 
after 3 days in all the brain areas. Maximum PChE inhibition was observed in 
striatum. After        9 days, recovery was noticed in PChE activity in all areas 
(inhibition ranged from 5 to 75%). Recovery from BuChE inhibition was 
noticed only in medulla and cortex. In other areas the inhibition was 
progressive (39-83%). After 15 days, recovery in AChE, BuChE and PChE 
activities compared to 9 days was noticed. Greater AChE recovery was 
observed in cerebellum whereas greater BuChE recovery was seen in 
cerebellum and medulla. Greater PChE recovery was seen in striatum and 
cerebellum. Hippocampal PChE remained inhibited by 50% even after 15 
days (Table 1). In tremors and convulsions the severity was more after 9 days 




Cholinergic impairment during OP toxicity is a well understood 
phenomenon.  However, the extent of damage in terms of ChE inhibition by 
phosalone on different brain areas and on other cholinesterases is poorly 
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understood. The present results show varied inhibitory patterns of 
cholinesterases upon phosalone toxicity.  Earlier studies carried on frog   
brain   areas   showed Inhibition of AChE by phosalone (Balasundaram and 
Selvarajan, 1990). Their observations are in agreement with the present 
results in rat brain areas and also demonstrate the development of 
symptomatic tolerance to phosalone by the animals, as judged by the gradual 
disappearance of overt manifestations of toxicity like tremors and 
convulsions with multiple sub-chronic dosing over an extended period of 
time (Russell et al., 1986; Swamy et al., 1993). Frequency and magnitude of 
signs and symptoms like tremors and convulsions are dependent on the 
inhibition of AChE activity. Striatum is the area associated with tremors and 
convulsions (Siegel, 1991). In the present study we have noticed the 
inhibition of AChE and BuChE activities by 89% and 82% respectively in 
striatum when peak levels of tremors and convulsions were observed (Table 
1). Normalcy in behavior was restored earlier than the recovery in enzyme 
activity or before ACh levels return to normal (Hoskins et al., 1986). It could 
be this possibility in the present study accounting for the disappearance and 
decline of tremors and convulsions from the 9th  day  to  the  15th  day,  in  
addition  to  the  recovery of both AChE and BuChE activities to a major 
extent. Recent studies emphasize that subsensitivity of muscarinic receptors 
leads to the development of tolerance and this subsensitivity was noted when 
55% AChE inhibition occurred (Russell et al., 1975). According    to    this   
notion, during   symptomatic behavioral tolerance to phosalone receptor 
mechanisms appear to be in operation. Van Dongen and Wolthius (1989) 
further demonstrated that more than a simple alteration of the number of 
receptors, a non-competitive modulation of muscarinic receptor binding is 
involved in the development of behavioral tolerance. This area is to be 
looked into for further understanding the mechanism of phosalone-induced 
tolerance. 
 
Reports on cholinesterases during behavioral tolerance indicated both 
continued inhibition of the enzyme as well as partial recovery of the enzyme 
at later periods (Sivam et al., 1984; Russell et al., 1986) with or without 
recovery in AChE activity (Sivam et al., 1983 and Gupta et al., 1985). In the 
phosalone-induced tolerance, recovery of AChE activity seems to be in 
operation. The inhibition of cholinesterases was found be varied among brain 
regions. Striatal ACE activity was inhibited more in malathion-tolerant 
animals (Barthalomew et al., 1985), hippocampal and striatal AChE was 
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more inhibited in disulfoton-tolerant rats (Costa and Murphy, 1982). In the 
present study, greater inhibition of AChE and BuChE was observed after 9 
days in striatum with lower inhibition initially. More number of cholinergic 
neurons in striatum (Ehlert et al., 1980) and greater activity in this region 
might have reduced the effect of phosalone initially which, however, did not 
continue as multiple doses of phosalone were given. Earlier recovery of 
AChE in CB and HP is interesting as these areas are associated with motor 
functions, learning and memory. 
 
The role of pseudocholinesterases during the toxicity/tolerance of OP 
compounds is not clear. Their presence is significant in plasma and blood 
vessels of brain (Friede and Fleming, 1964). Popularly known as scavengers 
or sinks, these enzymes found in plasma and erythrocytes have the ability to 
reduce the concentration of toxic chemicals (OP) entering the CNS (Clement, 
1984; Sterri and Fonnum, 1984). 
 
BuChE was found to decrease the inhibitory power of many OPs (Pla and 
Johnson, 1989). Role of BuChE during the development of tolerance to 
monocrotophos was earlier suggested (Swamy and Murali Mohan, 1992). In 
the present study earlier response of BuChE, that is greater inhibition after 1 
day then AChE, gains significance as it shows reacting first to phosalone 
toxicity than AChE in brain areas. Greater inhibition of PChE after 3 days is 
also interesting. It appears that these enzymes have their role in the 
development of tolerance, particularly earlier recovery of PChE in striatum 
and cerebellum by 15 days. 
 
Conclusions 
The present study demonstrates the occurrence of behavioral/symptomatic 
tolerance to ¼ LD50 daily dose of phosalone as the dosing is continued.  
BuChE and PChE activities by their recoveries from inhibition seem to 
contribute to this. The varied effects of phosalone on different brain areas 
shows further that the potential toxicity of OP compounds differs from 
chemical to chemical and among different brain regions (Singh, 1985). 
Homeostatic mechanisms by way of pseudocholinesterases taking over the 
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Table 1: Changes in AChE , BuChE and PChE activities in different brain regions of male albino rats, exposed to a 1/4LD50 of 
phosalone for 15 days 
 
 
AChE (µmoles of acetylthiocholine iodide hydrolyzed/mg protein/min) 
S/No  Region Control 1 Day %change 3 Days %change 9 Days %change 15 Days %change 
           
1 CT 5.08±0.63 1.58±0.13 -68.90 1.56±0.07 -69.29 1.27±0.6 -75.00 3.42±0.6 -32.68 
2 CB 3.18±0.94 1.94±0.16 -38.99 1.43±0.08 -55.03 1.63±0.19 -48.74 3.43±.31 +7.86 
3 ST 21.20±0.72 16.14±0.37 -23.87 13.46±0.56 -36.51 2.22±0.98 -89.53 12.35±2.7 -41.75 
4 HP 6.97±0.29 5.65±0.37 -18.94 2.61±0.19 -62.55 2.54±0.52 -63.56 5.6±0.32 -19.66 
5 MD 4.55±0.88 3.17±0.13 -30.33 2.9±0.31 -36.26 2.95±0.08 -35.17 3.12±0.38 -31.43 




        
 
BuChE (µmoles of butyrylthiocholine iodide hydrolyzed/mg protein/min) 
1 CT 0.51±0.08 0.1±0.005 -80.32 0.21±.03 -58.82 0.23±.06 -54.90 0.25±0.03 -50.98 
2 CB 0.38±0.03 0.15±.006 -60.50 0.23±.05 -39.47 0.33±0.02 -13.16 0.36±0.03 -5.26* 
3 ST 0.72±0.01 0.11±.002 -84.70 0.07±.02 -90.28 0.30±0.02 -58.33 0.48±.02 -33.33 
4 HP 0.58±0.19 0.11±.004 -81.03 0.10±.007 -82.76 0.28±0.04 -51.73 0.34±0.01 -41.38 
5 MD 0.62±0.07 0.17±.002 -72.60 0.26±.04 -58.07 0.45±0.05 -27.42 0.61±0.03 -1.61* 
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PChE (µmoles of acetylthiocholine iodide hydrolyzed/mg protein/min) 
1 CT 0.23±0.06 0.17±0.03 -26.09 0.13±0.003 -43.48 0.17±0.003 -26.09 0.21±0.07 -8.70* 
2 CB 0.20±0.02 0.13±0.005 -35.00 0.03±0.002 -85.00 0.19±0.08 -5.00* 0.22±0.04 +10.00 
3 ST 0.28±0.07 0.13±0.002 -53.57 0.02±0.005 -90.00 0.24±0.05 -14.29 0.28±0.05 0.00 
4 HP 0.32±0.01 0.08±0.01 -75.00 0.05±0.02 -84.38 0.16±0.004 -50.00 0.20±0.04 -37.50 
5 MD 0.56±0.22 0.26±0.02 -53.57 0.07±0.03 -87.50 0.31±0.05 -44.64 0.44±0.08 -21.43 
 
Values are ± SD of six individual observations of six animals each. Control values are ±SD of 8-10 individual observations 
of 6 animals each. Values are significantly different from controls at P < 0.05 (SNK test). *Indicates no significance. 
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